MedMen Enterprises Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 24, 2022
For the six months, sales was USD 59.6 million compared to USD 72.25 million a year ago. Net loss was USD 12.05 million compared to USD 74.36 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago.